News
The pharma major's consolidated net profit jumped 23.04% to Rs 662 crore in Q4 FY25 as against Rs 538 crore recorded in Q4 FY24.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback